Stoke Therapeutics, Inc.STOKNASDAQ
Loading
Gross Margin Over TimeStrong
Percentile Rank63
3Y CAGR-0.4%
Studio
Year-over-Year Change

Gross profit as a percentage of revenue

3Y CAGR
-0.4%/yr
Annual compound
Percentile
P63
Within normal range
vs 3Y Ago
1x
Modest growth
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM98.89%-1.1%
2024100.00%0.0%
2023100.00%0.0%
2022100.00%-
20210.00%-
20200.00%-
20190.00%-
20180.00%-
20170.00%-